Esidrix

Quick links to important sections

Esidrix

Method of action: Diuretic

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Esidrix

Quick Facts

Property Description
Active ingredient Hydrochlorothiazide (HCTZ)
Form Oral Tablet
Pharmacological class Thiazide Diuretic, Antihypertensive Agent
General Purpose Fluid volume management, Blood pressure reduction
Origin Synthetic Compound (Sulfonamide derivative)

What Type of Medicine is Esidrix?

Esidrix is the trade name for the active drug substance Hydrochlorothiazide (HCTZ), which is definitively classified as a thiazide diuretic and is clinically recognized as an effective antihypertensive agent. This synthetic compound is chemically characterized as a benzothiadiazine derivative and belongs to the larger class of sulfonamides. HCTZ is one of the most frequently prescribed diuretics, confirming its established role as a foundational treatment option.


Composition, Form, and General Purpose

The composition of Esidrix consists of the single active component, Hydrochlorothiazide, presented as an oral tablet taken by mouth. The drug's general therapeutic purpose focuses entirely on managing the body's circulating fluid volume. The main mechanism of thiazides involves increasing the urinary excretion of sodium and chloride ions. This action indicates that the medicine functions by causing the kidneys to remove excess salt, which subsequently draws out excess water to help reduce the fluid load on the cardiovascular system. This fluid reduction is the core benefit for patients, as it assists in the crucial goal of maintaining reduced and steady blood pressure.

What side effects are possible with Esidrix?

Possible side effects and safety information

The safety profile of Esidrix (Hydrochlorothiazide, HCTZ) is organized in official regulatory documents based on the frequency and system-organ class of documented adverse reactions. The primary safety concerns revolve around metabolic and fluid balance changes, which are considered common in this class of medicine.

Frequency and System-Organ Classifications

Adverse effects commonly documented include electrolyte imbalances (such as hypokalemia, hyponatremia, and hypochloremic alkalosis) and metabolic disturbances (hyperglycemia, hyperuricemia, and hyperlipidemia). Effects on the Nervous System like headache and dizziness are also frequently cited. Reactions classified as rare include jaundice and pancreatitis, while Acute Respiratory Distress Syndrome (ARDS) is a documented very rare reaction.

Serious Adverse Reactions and Population Safety

Official labels describe specific serious adverse reactions, including the risk of Acute Angle-Closure Glaucoma, an idiosyncratic reaction that typically occurs within weeks of initiation and can lead to permanent vision loss if untreated. Long-term use of HCTZ is also associated with an increased risk of Non-melanoma skin cancer (NMSC), which is correlated with increasing cumulative dose.

Safety notes specify restrictions for certain populations and conditions. The medicine is contraindicated in patients with anuria or known hypersensitivity to sulfonamide-derived drugs. Use requires caution in patients with severe renal impairment (as it may precipitate azotemia) or hepatic impairment, where minor fluid changes can potentially lead to hepatic coma.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Esidrix (Hydrochlorothiazide) overdose centers on the manifestations of excessive fluid and electrolyte loss.


Overdose Scope

Overdose is documented to cause Profound Fluid and Electrolyte Depletion, resulting in severe dehydration, Hypokalemia (low potassium), and Hyponatremia (low sodium). Clinical presentations often include severe Hypotension (low blood pressure), confusion, drowsiness, muscle cramps, vomiting, and extreme weakness.

The most severe, life-threatening outcomes affect the Cardiovascular and Central Nervous Systems. These may include cardiac arrhythmias and major neurological events such as seizures or coma, which are listed as critical manifestations. Regulatory documents note that for patients also taking digitalis, the resulting low potassium may heighten the risk of severe arrhythmias. Furthermore, no specific antidote is known for this overdose.


Emergency Response and Classification

Management is strictly symptomatic and supportive, requiring correction of the fluid and electrolyte imbalances. This may involve procedures like administering activated charcoal or performing gastric lavage. Continuous monitoring of vital signs and heart function (ECG) is often required.

Immediate medical attention is necessary. Government guidance mandates individuals to seek emergency medical attention right away or call a Poison Help line if an overdose is suspected. Urgent help must be summoned immediately if the affected person collapses, is experiencing seizures, has difficulty breathing, or cannot be awakened.

Therapeutic Uses of Esidrix

What Esidrix Treats: Main Uses and Benefits

Esidrix (Hydrochlorothiazide, HCTZ) is a well-established medication that is considered relevant for providing symptomatic support in two primary therapeutic areas.

Sustaining Control Over Symptoms Related to Systemic Imbalance

Esidrix is primarily used as a foundational, long-term therapy for managing chronic, elevated systemic arterial pressure. The medication is applied in situations requiring supportive symptom management and is considered relevant for easing the symptoms associated with the long-term cardiovascular burden. It is commonly used across conditions presenting with systemic or localized discomfort, including those involving episodic or fluctuating manifestations like fluid retention and pressure elevation.

Symptomatic Support for Fluid Volume and Discomfort

This medication may be part of symptomatic management for symptoms that interfere with daily functioning and create noticeable physiological strain. It is relevant for easing symptoms that cluster into patterns requiring supportive management, such as visible swelling in the extremities. This process helps improve day-to-day comfort during symptomatic phases and supports a more manageable experience when symptoms intensify.

“Used across domains where additional symptomatic support is needed, the medication supports patients during difficult episodes by easing distress.”


Quick Fact: Symptomatic Support for Fluid Volume
Symptom Domain Manifestations of excess fluid volume (Edema)
Use Context Foundational, long-term chronic therapy
Primary Benefit Supports general well-being and helps ease the overall symptom load

Eligibility and Restrictions for Use

The eligibility to use Esidrix (Hydrochlorothiazide) is strictly determined by governmental regulatory documentation, which defines absolute prohibitions and restrictions based on specific medical conditions and patient populations.

Contraindicated Populations

Use is strictly contraindicated for patients with anuria (inability to pass urine) and in those with known hypersensitivity to Hydrochlorothiazide or any sulfonamide-derived drug. The medicine is also prohibited for patients with severe renal impairment (creatinine clearance below 30 mL/min), severe hepatic impairment, or certain refractory electrolyte imbalances such as hypokalemia or hypercalcemia.

Organ Function and Comorbidities

Use requires caution in populations with impaired hepatic function or progressive liver disease, as minor fluid changes may precipitate hepatic coma. Caution is also necessary for patients with Systemic Lupus Erythematosus (SLE), as the regulatory label reports the possibility of exacerbation. Conditional use is warranted for those with gout or hyperuricemia and diabetes mellitus due to the potential to affect these underlying conditions.

Age and Physiological States

Use is established for adult patients and is documented for pediatric patients (including infants over six months) under specific guidelines. Older adults may exhibit increased sensitivity, requiring special consideration. Routine use is considered inappropriate in pregnancy, and the drug is not recommended for nursing mothers, as it passes into breast milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Hydrochlorothiazide (Esidrix) is subject to specific interaction patterns documented in regulatory labeling that define risks and co-administration requirements.

Documented Pharmacodynamic and Pharmacokinetic Interactions

Co-administration with Lithium is generally restricted because the diuretic reduces the renal clearance of Lithium, resulting in a high risk of toxicity. Similarly, the combination with Aliskiren-containing products is not recommended in patients with diabetes mellitus or specific renal impairment.

Interacting Substance/Class Official Interaction Description
Other Antihypertensive Drugs Results in an additive effect or potentiation of blood pressure reduction.
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Can reduce the diuretic and antihypertensive effects of Hydrochlorothiazide.
Corticosteroids/ACTH May lead to intensified electrolyte depletion, specifically hypokalemia.

Restrictions and Timing Requirements

Interactions with Cholestyramine and Colestipol resins result from the resins impairing the absorption of Hydrochlorothiazide. Accordingly, regulatory documents require that administration of Esidrix must be separated in time from these resins. Potassium supplements and Potassium-sparing diuretics are not recommended due to an elevated risk of hyperkalemia.

Population-specific notes include the caution that the drug's elimination half-life is prolonged in patients with renal impairment, and that minor electrolyte changes may precipitate hepatic coma in patients with hepatic impairment.

Mechanism of Action

Mechanism of Action

The primary mechanism of Hydrochlorothiazide is the direct inhibition of the Sodium Chloride Cotransporter (NCC) ( SLC12A3), a specific membrane protein located on the apical side of the cells within the kidney’s distal convoluted tubule (DCT). This action functionally blocks the co-transport of Na^+ and Cl^- ions, halting their reabsorption from the tubular fluid back into the bloodstream.

This cellular blockade initiates a rapid, dose-dependent mechanistic cascade: the unreabsorbed salt osmotically retains water, leading to natriuresis and subsequently diuresis (increased water excretion). The resultant fluid loss reduces the body's total circulating Plasma Volume and Extracellular Fluid (ECF), consequently decreasing the pressure and cardiac output. Over sustained exposure, the mechanism also involves a secondary, chronic effect on the vasculature, promoting the relaxation of blood vessel walls and reducing Peripheral Vascular Resistance (PVR). This dual volume and vascular action establishes the drug's sustained physiological effect.

Dosage and Administration Information

Official Administration Guidelines

Esidrix, which contains the active substance Hydrochlorothiazide (HCTZ), is administered exclusively via the oral route as a tablet. Official usage protocols are defined by the required daily dosage, frequency patterns, and specific rules for administration that ensure proper drug action.


Dosing and Scheduling Protocols

Usage Context Standard Adult Labeled Regimen Frequency and Pattern
Hypertension Initial dose is typically 12.5 mg to 25 mg daily. The usual maximum dose is 50 mg daily. Administered once daily or in two divided doses.
Edema Doses range from 25 mg to 100 mg daily. Administered as a single dose or in divided doses. Intermittent therapy (e.g., alternate days or 3 to 5 days each week) may be considered.

Labeled Administration Instructions

The medication may be taken with or without food. Certain patient populations require modified administration principles. For instance, dosing for pediatric patients (children 6 months to 12 years) is weight-based, generally starting at 1 to 2 mg/kg per day, with specific maximum daily limits. The use of HCTZ is generally not recommended in patients with severe renal impairment (creatinine clearance < 30 mL/min).

To ensure proper absorption, Hydrochlorothiazide must be administered several hours apart from bile acid sequestrant resins (e.g., cholestyramine).

Recent Clinical Evidence

Esidrix: Recent Clinical Evidence

Esidrix (hydrochlorothiazide) is a long-established medication in the thiazide diuretic class. Clinical evidence primarily supports its use for managing hypertension (high blood pressure) and treating edema (fluid retention) associated with certain conditions, such as heart failure, liver cirrhosis, or the use of specific therapies like corticosteroids.


Evidence in Hypertension Management

Large-scale clinical trials and systematic reviews have studied the role of hydrochlorothiazide in treating high blood pressure, often as an initial therapy or in combination with other antihypertensive agents.

  • Blood Pressure Reduction: Studies show that hydrochlorothiazide, commonly used at doses between 12.5 mg and 25 mg daily, is associated with a measurable reduction in both systolic and diastolic blood pressure.
  • Cardiovascular Outcomes: Thiazide-type diuretics, as a class, have a body of evidence that supports a reduction in the risk of stroke and major cardiovascular events in individuals with hypertension over long-term treatment.
  • Comparative Findings: Some comparative analyses, specifically those using 24-hour ambulatory blood pressure monitoring, have suggested that hydrochlorothiazide at lower doses may be less effective in lowering blood pressure than certain other antihypertensive drug classes, such as ACE inhibitors or ARBs, or the thiazide-like diuretic chlorthalidone.

Other Clinical Observations

Research has also explored hydrochlorothiazide's effects beyond its primary indications:

  • Bone Density: Observational studies have noted a potential association between thiazide diuretic use and a slower rate of bone mineral density loss in certain populations, which may suggest a benefit for bone health.
  • Skin Cancer Risk: Certain studies have identified an association between long-term, high-dose use of hydrochlorothiazide and an increased risk of developing certain types of non-melanoma skin cancer.

Frequently Asked Questions (FAQ)

Common questions about Esidrix (FAQ)


Q: How long does it typically take for Esidrix to start working?

According to the official pharmacological documents, the onset of action is observed within approximately 2 hours of taking a dose. The medication typically reaches its peak effect around 4 hours after administration, and its activity is known to persist in the body for up to 24 hours.


Q: What happens if a dose of Esidrix is missed?

Official instructions advise taking a missed dose as soon as it is remembered. However, if the time for the next scheduled dose is near, the regulatory instruction is to skip the missed dose and continue the regular schedule. Regulatory guidance cautions against taking a double dose to make up for a forgotten one.


Q: Is it safe to drink alcohol in moderation while on Esidrix?

Official safety warnings state that consuming alcohol can increase the risk of a side effect called orthostatic hypotension. This is a sudden drop in blood pressure that can cause dizziness or lightheadedness when moving from sitting or lying down to a standing position. The existence of this warning highlights the need for careful consideration when consuming alcohol while on this medication.


Q: What does it mean if official documents describe Esidrix as a thiazide diuretic?

A thiazide diuretic is a pharmacological classification that describes the drug's function. According to official documents, it works by instructing the kidneys to remove excess salt and water (diuresis) from the body. This process, known as diuresis, helps reduce the total circulating fluid volume, which is the core mechanism for lowering blood pressure.


Q: Why do some people experience muscle cramps when taking Esidrix?

Regulatory safety documents list muscle spasm as a documented adverse reaction to Esidrix. Muscle pain or cramps are also recognized as potential warning signs of an underlying electrolyte imbalance, such as low potassium levels, which is a common effect of this class of diuretic medicine.


Q: Does Esidrix cause dehydration?

Official product information notes that safety concerns include the risk of fluid and electrolyte imbalance due to the drug's mechanism of increasing water excretion. Symptoms like dry mouth, thirst, and weakness are documented as warning signs of this imbalance. Regulatory documents emphasize that the occurrence of these symptoms may indicate a need for professional medical assessment.


Q: Are there certain foods or drinks to avoid while taking Esidrix?

The drug's safety information states that alcohol may increase the risk of orthostatic hypotension, which is dizziness or lightheadedness upon standing. While there are no general food restrictions, regulatory information notes that if a specific low-salt diet or recommendations regarding potassium-rich foods have been prescribed, these instructions must be carefully adhered to, as the drug can significantly affect the body’s salt balance.


Q: Does Esidrix interact with supplements like magnesium or calcium?

Official reports indicate that Esidrix may influence the body's mineral balance, specifically leading to a loss of magnesium and changes in calcium levels. Regulatory safety documents caution that the use of mineral supplements, such as magnesium or calcium, should be reviewed by a qualified professional due to the potential for these electrolyte changes.


Q: How is Esidrix eliminated from the body?

The official pharmacokinetic profile confirms that Esidrix is eliminated from the body primarily through the renal pathways, meaning via the kidneys. Over 95% of the dose that is absorbed is generally excreted unchanged in the urine. This process of elimination is important for healthcare providers to consider, particularly for individuals with reduced kidney function.


Q: Does the efficacy of Esidrix change over time?

Official information on the drug's action confirms that the effects evolve over time. Initially, the effect is primarily due to reduced blood volume, but with chronic administration, the mechanism adapts. The long-term efficacy is maintained through a secondary effect that involves decreasing peripheral vascular resistance, which is the pressure exerted by the blood vessels.


Q: Can taking Esidrix affect results from lab tests?

Yes, regulatory precautions state that taking Esidrix may affect the results of certain clinical assessments. This includes tests for parathyroid function. Furthermore, ongoing blood and urine tests are usually required during treatment to safely monitor for the expected changes in electrolytes and other potential metabolic effects of the medicine.


Q: Are there specific symptoms that require immediate medical attention while taking Esidrix?

Official patient safety information documents several symptoms that may be associated with serious adverse reactions, which should be immediately reported to a healthcare professional. These include signs of severe dehydration (like extreme thirst or dry mouth), symptoms of serious electrolyte imbalance (such as muscle cramps or a fast heartbeat), and signs of a severe allergic reaction (like hives, difficulty breathing, or swelling of the face).


Q: Is there a specific time of day Esidrix is generally taken?

Official prescribing information states the drug is typically taken once or twice a day. Some patient guidance suggests taking diuretic medicines, like this one, earlier in the day. This is a common practice intended to minimize sleep disruption that could be caused by the need for frequent urination during the night.


Q: Do you gain or lose weight when taking Esidrix?

As a diuretic, the drug's initial effect often leads to weight loss resulting from the increased fluid excretion. However, studies have also explored the possibility of certain long-term metabolic changes. These changes, such as effects on blood sugar, might potentially contribute to weight changes over sustained use.


Q: What is the risk of sunburn or sun sensitivity while using Esidrix?

Official safety information notes that photosensitivity (increased sensitivity to sunlight) is a documented adverse reaction. To mitigate this risk, regulatory information notes that due to this documented photosensitivity, limiting sun exposure and using sun protection are generally recommended mitigating measures. This caution is especially relevant for long-term users, due to an association noted in some studies between cumulative use and the risk of Non-melanoma skin cancer.


Q: Does Esidrix cause fatigue or low energy?

While not listed as a primary side effect, patient safety information indicates that weakness and lethargy are documented symptoms of the fluid and electrolyte imbalances caused by the drug. Feeling generally tired or having low energy is noted in some official patient resources as a common side effect.


Q: Can Esidrix be stopped abruptly?

Regulatory patient information for medications used to manage high blood pressure, including this class, includes a specific warning against abrupt cessation. The instruction is that the medicine should not be stopped suddenly unless the individual has been directed to do so by a healthcare professional.


Q: Are there any official recommendations regarding driving or operating machinery while taking Esidrix?

Official precautions warn that the medicine may cause effects such as dizziness or lightheadedness. Due to the potential for impaired mental alertness, patient guidance recommends that individuals avoid driving, operating machinery, or engaging in hazardous activities until the drug's effects on them are known.


Q: What are the ingredients in Esidrix besides the active drug?

The single active component is Hydrochlorothiazide. Regulatory documents list that the tablets also contain inactive ingredients, which are necessary to form the tablet but do not contribute to the medical effect. These inactive ingredients can vary by the specific product manufacturer but often include standard components like microcrystalline cellulose, magnesium stearate, and titanium dioxide.

How should Esidrix be stored and disposed of?

How to Store and Dispose of Esidrix

Esidrix (hydrochlorothiazide) tablets must be stored according to regulatory requirements to maintain product stability and ensure safety. Storage is required at Controlled Room Temperature (CRT), which ranges from 20 C to 25 C (68 F to 77 F). The medication must be kept in a tight, light-resistant container and protected from excessive light.

Child-Safety and Disposal Rules

It is mandatory to keep this and all medications out of the sight and reach of children and use a container with a child-resistant closure. For disposal, the U.S. FDA does not recommend flushing the tablets. Unused or expired medication should be taken to a drug take-back program or, if unavailable, mixed with an undesirable substance (e.g., used coffee grounds) and placed in a sealed container for household trash, adhering to local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Esidrix found in:

A-Z Index: